ABBA Therapeutics was selected for BaseLaunch program
Basel, Switzerland – 18.09.2017 – ABBA Therapeutics was selected to participate BaseLaunch program from more than 100 international applications. ABBA Therapeutics will receive non-dilutive funding CHF 10,000 for continuing its pipeline development.
About ABBA Therapeutics
ABBA Therapeutics is a Swiss biotechnology company founded in Basel in 2016. ABBA Therapeutics focuses on developing next-generation antibody drugs for cancer immunotherapy. The lead project is to develop therapeutic antibodies targeting a novel immune checkpoint family member across both lymphoid and myeloid lineages for a better and broader response of cancer patients to IO therapies.
Further contact: firstname.lastname@example.org; www.abba-therapeutics.com
BaseLaunch was set up in 2017 by BaselArea.swiss and collaborates closely with digital switzerland’s Kickstart Accelerator as its healthcare vertical. BaseLaunch has set itself the task of accelerating the development of promising and pioneering healthcare startups and strengthening the leadership position of the Basel region as the pre-eminent life sciences hub. The accelerator program offers funding, expertise, and infrastructure and industry access to promising new ventures, and integrates them into one of the most dynamic biotech and pharma ecosystems in Europe. BaseLaunch enjoys the backing of healthcare partners Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer and Roche as well as other public and private partners. Projects are reviewed by a selection committee from international healthcare industries and investment companies.
Further contact: www.baselaunch.ch
BaselArea.swiss is the office for promoting innovation and inward investment for the northwest cantons of Basel-Stadt, Basel-Landschaft and Jura. BaselArea.swiss currently has an annual budget of 3.6 million francs, provided by the three cantons and by the State Secretariat for Economic Affairs (SECO). The core function of BaselArea.swiss is to promote the strengths of northwest Switzerland as a center for business and to help both Swiss and foreign entrepreneurs and companies implement their innovation and business projects in the region. With its extensive information platform and regular innovation reports, BaselArea.swiss contributes to the sustainable positioning of the Basel region as a leading center for innovation and commerce.
Further contact: Thomas Brenzikofer, email@example.com, +41 79 509 84 50